Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 9/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 9/20 | 0.39 |
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.34 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2802426 | 0.92 | IDO1 (0.43) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2803820 | 0.91 | S1PR5 (0.37) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2801247 | 0.86 | IDO1 (0.39) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2801078 | 0.85 | RBP4 (0.44) | — | |
| SCHEMBL2803162 | 0.85 | IDO1 (0.38) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2800886 | 0.85 | IDO1 (0.43) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2801703 | 0.84 | IDO1 (0.38) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2801347 | 0.83 | S1PR5 (0.38) | IDO1AVPR1APRSS1PRSS2PRSS3 | |
| SCHEMBL2801650 | 0.82 | AVPR1A (0.46) | AVPR1A | |
| SCHEMBL15698540 | 0.82 | AVPR1A (0.41) | IDO1AVPR1APRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2206714-B1 | AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES | KYOWA HAKKO KIRIN CO LTD (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-8729264-B2 | Agent for prevention and/or treatment of skin diseases | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20100256134-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2206714-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES | Kyowa Hakko Kirin Co., Ltd. (JP) | 2010-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256134-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES | TYR, CUTA, SERPINB1 | IDO1 2086/4885AVPR1A 4789/4885PRSS1 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.